Cargando…

Successful extended use of Impella 5.5 as a bridge to heart transplantation

We present the case of a 60-year-old gentleman who was admitted with acute-on-chronic cardiogenic shock and was supported with axillary Impella 5.5® for 123 days prior to heart transplantation. Total length of temporary mechanical circulatory support (MCS) was 132 days, which included 9 days with an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharaf, Omar M, Diaz-Ayllon, Hannia P, Myers, Elisha M, Ahmed, Mustafa M, Bleiweis, Mark S, Jeng, Eric I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244061/ https://www.ncbi.nlm.nih.gov/pubmed/37293331 http://dx.doi.org/10.1093/jscr/rjad262

Ejemplares similares

Short‐term outcomes of heart transplant patients bridged with Impella 5.5 ventricular assist device
por: Haddad, Osama, et al.
Publicado: (2023)

Transinnominate Impella 5.5 insertion as a bridge to transplantation in a pediatric patient in refractory cardiogenic shock
por: Bouhout, Ismail, et al.
Publicado: (2022)

Durable biventricular assist device support for 1212 days as a bridge to heart transplantation
por: Sharaf, Omar M, et al.
Publicado: (2023)

Single center experience and early outcomes of Impella 5.5
por: Funamoto, Masaki, et al.
Publicado: (2023)

Unloading, ablation, bridging and transplant: different indications and treatments using the Impella 5.5 as longer-term circulatory support in one patient—an interdisciplinary case report
por: Volgmann, Constanze, et al.
Publicado: (2023)

Aortic Valve Leaflet Disruption: A Severe Complication of Impella 5.5
por: Ghannam, Alexander D, et al.
Publicado: (2021)

Impella 5.5 Versus Centrimag: A Head-to-Head Comparison of Device Hemocompatibility
por: Roka-Moiia, Yana, et al.
Publicado: (2020)

Impella 5.0 supported oncological surgery as bridge to LVAD
por: Montisci, Andrea, et al.
Publicado: (2020)

Single center first year experience and outcomes with Impella 5.5 left ventricular assist device
por: Rock, Joanna R., et al.
Publicado: (2022)

Case report: management of refractory cardiogenic shock with Impella 5.5 in patients with transcatheter aortic valves
por: Harada, Rakushumimarika, et al.
Publicado: (2023)

Post-Myocardial Infarction Ventricular Septal Defect Successfully Treated with Impella as Bridge to Cardiac Transplantation
por: Giudicatti, Lauren, et al.
Publicado: (2022)

A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre
por: Kennel, Peter J., et al.
Publicado: (2021)

Effect of Impella 5.5 on Preexisting Functional Mitral Regurgitation in Patients with Heart Failure–Related Cardiogenic Shock
por: Kataria, Rachna, et al.
Publicado: (2022)

Impella 5.0/5.5 Implantation via Innominate Artery: Further Expanding the Opportunities for Temporary Mechanical Circulatory Support
por: Bertolin, Stephanie, et al.
Publicado: (2022)

Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock
por: Madjarov, Jeko M., et al.
Publicado: (2021)

Crossing the Bridge to Heart Transplantation: Biventricular Impella to Support an Unstable LVAD Patient
por: Vaishnav, Joban, et al.
Publicado: (2020)

Tissue plasminogen activator for axillary Impella 5.0 with heparin-induced thrombocytopenia as a treatment of choice for acute Impella thrombosis: a case report
por: Merino, Elena, et al.
Publicado: (2023)

A successful bridge to recovery with Impella 5.0 and subsequent hybrid cardiac resynchronization therapy in systemic right ventricle failure: a case report
por: Iwasaki, Keiichiro, et al.
Publicado: (2023)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Impella bridge to durable LVAD: A short run for a long slide
por: Wisniewski, Alex M., et al.
Publicado: (2022)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

Severe Left Ventricular Failure Unmanageable by Impella 5.0
por: Mano, Akiko, et al.
Publicado: (2023)

Weaning from Impella and mobilization of Impella patients
por: Bertoldi, Letizia Fausta, et al.
Publicado: (2021)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review
por: Valdes, Carlos A., et al.
Publicado: (2023)

Adobe Photoshop 5.5. /
Publicado: (1999)

Severe Ovarian Hyperstimulation Syndrome in the Setting of In Vitro Fertilization Treatment
por: Diaz Ayllon, Hannia, et al.
Publicado: (2023)

Short-term mechanical support with the Impella 5.x for mitral valve surgery in advanced heart failure—protected cardiac surgery
por: Osswald, Anja, et al.
Publicado: (2023)

Impella RP as a bridge to cardiac transplant for refractory late right ventricular failure in setting of left ventricular assist device
por: Randhawa, Varinder Kaur, et al.
Publicado: (2020)

Non-disulfide-Bridge Peptide 5.5 from the Scorpion Hadrurus gertschi Inhibits the Growth of Mycobacterium abscessus subsp. massiliense
por: Trentini, Monalisa M., et al.
Publicado: (2017)

Use of Extracorporeal Membrane Oxygenation and Impella as Bridge to Surgery Through Imaging for Cardiogenic Shock
por: Anastasius, Malcolm, et al.
Publicado: (2022)

Novel Combination of Impella and Extra Corporeal Membrane Oxygenation as a Bridge to Full Recovery in Fulminant Myocarditis
por: Narain, Sachin, et al.
Publicado: (2012)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
por: Hotta, Naoshi, et al.
Publicado: (2020)

Impella 2.5 Insertion: Which Artery to Access When Femoral Is not an Option?
por: Koutroumpakis, Efstratios
Publicado: (2020)

Brachial Artery Access as a Novel Alternative for Impella 2.5 Insertion
por: Karami, Mina, et al.
Publicado: (2020)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Minimally invasive biventricular mechanical circulatory support with Impella pumps as a bridge to heart transplantation: a first‐in‐the‐world case report
por: Varian, Kenneth, et al.
Publicado: (2019)

Photoshop 5.5 práctico : guía de aprendizaje
por: Quirós Peñalva, Enrique
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_cjg28tfesfli3mlnuhfnfvga89